Co-inventor: CRISPR gene editing could have 'profound positive effect,' but ethics concerns remain

SALT LAKE CITY — Jennifer Doudna, who co-invented a gene editing technology that could transform how numerous genetic conditions are treated, says the process not only raises many hopes, but also brings concerns about "designer babies."Doudna, a professor of biochemistry and molecular biology at the University of California-Berkeley, is one of the authors of a 2012 paper describing a defense mechanism used by bacteria as the basis for a technology allowing for the precise, detailed editing